CM
PRTK

Crestline Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Crestline Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-71,799
Closed -$1.73M – 178
2017
Q2 		$1.73M Buy
+71,799
New +$1.73M 0.23% 50